Brighton Jones’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Brighton Jones's JAZZ Position: Q3 2026 in Review
Brighton Jones reduced its Jazz Pharmaceuticals (JAZZ) stake by 8% in Q3 2026, selling an estimated $46K and leaving 2,147 shares worth $497K. The position accounts for 0.01% of the portfolio, ranked #813.
Brighton Jones first reported a position in JAZZ in Q3 2013 and has held it in 21 quarters since. The position peaked at $562K in Q2 2026. 672 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- Brighton Jones held 2,147 shares of Jazz Pharmaceuticals worth $497K as of Q3 2026.
- Brighton Jones sold 186 Jazz Pharmaceuticals shares in Q3 2026, an estimated $46K.
- Jazz Pharmaceuticals made up 0.01% of Brighton Jones's portfolio in Q3 2026, its #813 holding.
- Brighton Jones first reported a position in Jazz Pharmaceuticals in Q3 2013 and has held it in 21 quarters since.
- Brighton Jones's Jazz Pharmaceuticals position peaked at $562K in Q2 2026.
- 672 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.